Next Article in Journal
Tetraphenylethene Derivatives Bearing Alkylammonium Substituents: Synthesis, Chemical Properties, and Application as BSA, Telomere DNA, and Hydroxyl Radical Sensors
Previous Article in Journal
Quality Control and Authentication of Black Betel Leaf Extract (Piper acre Blume) from East Kalimantan as an Antimicrobial Agent Using a Combination of High-Performance Liquid Chromatography and Chemometric Fourier Transform Infrared
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Supramolecular Assemblies of Fluorescent Nitric Oxide Photoreleasers with Ultrasmall Cyclodextrin Nanogels

1
Laboratory of Photochemistry, Department of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy
2
Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, Tokyo 102-8554, Japan
3
Graduate School of Science and Engineering, Saitama University, Saitama 338-8570, Japan
4
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, V.le, F. Stagno d’Alcontres, 31, I-98166 Messina, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2023, 28(15), 5665; https://doi.org/10.3390/molecules28155665
Submission received: 28 June 2023 / Revised: 20 July 2023 / Accepted: 21 July 2023 / Published: 26 July 2023

Abstract

:
Developing biocompatible nitric oxide (NO) photoreleasing nanoconstucts is of great interest in view of the large variety of biological roles that NO plays and the unique advantage light offers in controlling NO release in space and time. In this contribution, we report the supramolecular assemblies of two NO photodonors (NOPDs), NBF-NO and RHD-NO, as water-dispersible nanogels, ca. 10 nm in diameter, based on γ-cyclodextrins (γ-CDng). These NOPDs, containing amino-nitro-benzofurazan and rhodamine chromophores as light harvesting antennae, can be activated by visible light, are highly hydrophobic and can be effectively entrapped within the γ-CDng. Despite being confined in a very restricted environment, neither NOPD suffer self-aggregation and preserve their photochemical and photophysical properties well. The blue light excitation of the weakly fluorescent γ-CDng/NBF-NO complex results in effective NO release and the concomitant generation of the highly green, fluorescent co-product, which acts as an optical NO reporter. Moreover, the green light excitation of the persistent red fluorescent γ-CDng/RHD-NO triggers NO photorelease without significantly modifying the emission properties. The activatable and persistent fluorescence emissions of the NOPDs are useful for monitoring their interactions with the Gram-positive methicillin-resistant Staphylococcus aureus, whose growth is significantly inhibited by γ-CDng/RHD-NO upon green light irradiation.

Graphical Abstract

1. Introduction

Nitric oxide (NO) is a key mediator of many physiological processes, including vasodilation, neurotransmission and hormone secretion [1]. Moreover, the last two decades have witnessed additional and important roles this inorganic free radical plays, especially in cancer [2], wound-healing [3] and bacterial infections [4]. NO shows attractive advantages over conventional chemotherapy drugs and antibiotics, including the absence of multidrug resistance, multitarget activity, a broad spectrum of action and, as a result of its ephemeral nature, the confinement of its cytotoxic action over short distances (<200 µm) from its generation site. This has opened intriguing horizons for potential and innovative, therapeutic approaches based on the use of NO as unconventional therapeutic as either an alternative to or in combination with conventional drugs.
Due to its gaseous nature, it is difficult to deliver NO. This issue has inspired the development of a range of NO-releasing precursors that are able to store NO as a part of their molecular or macromolecular skeletons and deliver it in a controlled manner [5,6,7,8,9]. The spatiotemporal control of NO release is of particular relevance, since the therapeutic effects are strictly dependent on its doses and site of action. This has made NO releasers activatable by light stimuli, usually named NO photodonors (NOPDs), which are very appealing in view of the high spatiotemporal precision in the delivery process that they offer, in comparison to spontaneous NO releasers [10,11,12,13,14,15,16].
For practical bio-applications, the solubility of NOPDs in aqueous medium is highly desirable. Nanotechnology is very helpful in this regard, offering a variety of water-dispersible nanocontainers suitable for the covalent and non-covalent integration of otherwise water-insoluble NOPDs [17]. Nanotechnogical approaches also allow the concentration of a large number of NOPDs at a very restricted volume, increasing light harvesting properties and enabling the production of a burst of NO in a very small area.
In contrast to spontaneous NO releasers, one key aspect to be considered in the case of NOPDs encapsulated in host nanocarriers is related to the preservation of their photochemical behavior within the host. This is not trivial since, in many cases, specific intra- and inter-molecular guests’ interactions and/or the presence of steric constrains can dramatically affect the efficiency or nature, or both, of the desired photochemical reaction (i.e., NO photorelease).
Among the large variety of host nanocarriers, nanogels represent a class of promising and innovative materials as next-generation drug-delivery systems [18]. They are usually composed of polymeric chains dispersed in a large volume of liquid to form three-dimensional networks [19]. The main features of nanogels include relatively high drug encapsulation capacity, controllable dimensions and very low toxicity. Moreover, due to their small size and composition they show excellent optical transparency, which is an ideal pre-requisite for spectroscopic investigations and the photochemical activation of chromo-fluorogenic guest molecules. In recent years, cyclodextrins (CDs), cyclic oligosaccharides composed of six (α-CD), seven (β-CD) or eight (γ-CD) glucopyranose units linked by 1,4 bonds [20], have entered the limelight as suitable building blocks for the fabrication of nanogels [21,22,23,24]. The typical ability of CDs to form inclusion complexes with a variety of guest molecules due to differently sized hydrophobic cavities, is retained or even improved when CDs are polymerized into nanogels. Very recently, a novel method using emulsion polymerization and [dilauryl(dimethyl)]ammonium bromide for the preparation of uniform and ultrasmall γ-CD nanogels (γ-CDng) (Scheme 1) ca. 10 nm in diameter and with a zeta potential of ca. −1.5 mV at neutral pH has been reported [25]. This material exhibited superior inclusion properties than native CDs and, due to their reduced sizes, is expected to be able to avoid the undesired toxicity or tissue accumulation issues that are typical for larger sized nanogels [24].
On these grounds and stimulated by our ongoing interest on NOPDs for bio-applications [10,11,17], we considered of value of exploring the supramolecular assemblies of the above γ-CDng with two recently developed NOPDs, NBF-NO and RHD-NO (Scheme 1), based on amino-nitro-benzofurazan and rhodamine chromophores as light harvesting antennae, respectively [26,27]. The choice of these NOPDs is not random and is motivated by their common insolubility in water and their different photochemical properties. In fact: (i) NBF-NO is not fluorescent and its activation with blue light triggers the NO release with the concomitant generation of the highly green fluorescent product NBF, which acts as an optical reporter to monitor the NO release in real time [26]; (ii) RHD-NO exhibits persistent red fluorescence, and its activation with green light triggers the NO release without affecting the emissive properties [27]. In this contribution, we report the photochemical and photophysical properties of the above supramolecular assemblies and some preliminary antibacterial tests on methicillin-resistant Staphylococcus aureus (MRSA).

2. Results and Discussion

Solubility studies were performed by using a concentration of γ-CDng of 1 mg mL−1. Thin films of NBF-NO, obtained by drying a methanol solution of the NOPD at different concentrations, were stirred with an aqueous solution of γ-CDng, and the absorption spectra of the final solutions were recorded. The absorbance values at 380 nm (absorption maximum of NBF-NO) increased as a result of the encapsulation of the NOPD within the γ-CDng to form the γ-CDng/NBF-NO host–guest supramolecular assembly. A solubility limit of 5.5 μg mL−1 and an encapsulation efficiency of ca. 97% were obtained. Figure 1A (spectrum a) shows a representative absorption spectrum of the γ-CDng/NBF-NO complex. Both the absorption maximum and the spectral shape were very similar to those previously observed in methanol/water solution [26], accounting for the absence of significant self-aggregation of the guest within the host. This was confirmed by the photoreactivity of NBF-NO observed upon blue light irradiation. The absorption spectral changes reported in Figure 1 show the bleaching of the absorption band at 380 nm, accompanied by the formation of a new, intense absorption at 485 nm (inset Figure 1A).
Apart from the small shift due to the different polarity of the environment experienced by the NOPD, the observed spectral changes are basically similar to those already observed in methanol/water solution [26] and according with the formation of NBF as stable photoproduct. NBF is, in fact, characterized by the charge transfer band typical of the amino-nitrobenzofurazan moiety, which is restored after NO release and subsequent H-abstraction from the host by the anilinyl radical intermediate [26]. According to this view, NO release was observed via a direct method using an ultrasensitive NO electrode. Figure 1B shows that instantaneous release of NO occurs from the supramolecular nanoassembly upon blue light irradiation. The NO release is exclusively regulated by light stimuli as confirmed by alternating different light/dark cycles. The quantum yield for the NO photorelease, ΦNO, was ~0.16, a value very similar to that observed in methanol/water solution [26]. This similarity supports well the absence of self-quenching processes between the NOPD within the nanogel. Furthermore, this high photoreactivity is also the result of the active role of the CD units of the host, which provide easily abstractable hydrogens close to the anilinyl radical intermediate generated after the NO photorelease.
Analogously to its free form in organic solvent, NBF-NO exhibits low fluorescence emission when entrapped within the γ-CDng. However, irradiation of the supramolecular complex leads to a revival of the emission with λmax = 555 nm, typical of the NBF fluorophore (Figure 2A). The appearance of the green emission of the optical reporter NBF is well visible even to naked eye (Figure 2B) and provides readable information about the photogeneration of NO. The fluorescence decay observed at the end of the photolysis (Figure 2C) shows a bi-exponential behavior with the fast and the slow components having lifetimes τf = 1.02 ns (87.08%) and τs = 4.78 ns (12.92%). This bi-exponential decay probably reflects the different host compartments experienced by the NBF fluorophore inside the γ-CDng.
RHD-NO is based on the rhodamine chromophore, a green light antenna covalently linked to a nitroso-derivative appendage through a flexible spacer [27]. The mechanism of the NO release in this NOPD involves an intramolecular photoinduced electron transfer between the excited antenna and the nitroso moiety. The anilinyl radical intermediate generated after homolytic rupture of the N-NO bond leads to the stable photoproduct RHD after H-abstraction from the solvent (Scheme 1). In contrast to NBF-NO, RHD-NO shows a persistent and intense red/orange emission which does not change significantly after NO releases. Analogously to NBF-NO, RHD-NO is insoluble in water medium. However, also in this case, this NOPD can be effectively encapsulated in the γ-CDng to form the γ-CDng/RHD-NO host–guest supramolecular complex. A solubility limit of 4.8 μg mL−1 and an encapsulation efficiency of ca. 55% were obtained. Figure 3A (spectrum a) shows a representative absorption spectrum of the γ-CDng/RHD-NO complex and the actual image of the sample which shows the typical color of the rhodamine chromophore (inset Figure 3A). The close similarity of both absorption maximum and spectral shape to those previously observed in methanol/water solution [27] accounts for the absence of relevant self-aggregation processes of the guest within the host compartment. Interestingly, the encapsulation of the NOPD within the γ-CDng does not modify its photochemical reactivity. As illustrated in Figure 3A, irradiation of the complex with green light at 532 nm induces spectral changes characterized by the formation of a new absorption at ca. 400 nm. This band arises from the push–pull character typical of the nitroaniline moiety of the stable photoproduct RHD (Scheme 1), whose formation was complete in ca. 15 min (inset Figure 3A). According to this view, NO release exclusively regulated via green light stimuli was confirmed by its direct monitoring by alternating different light/dark cycles (Figure 3B). The quantum yield for the NO photorelease, ΦNO, was ~10−3, a value very similar to that reported in methanol/water solution [27].
As shown in Figure 4A (spectrum a), RHD-NO also exhibits a red/orange fluorescence emission typical of the rhodamine fluorophore when encapsulated within the γ-CDng, according to the photophysical behavior observed for the free guest [27]. The emission can be observed even with the naked eye (inset Figure 4A) and was well preserved after the irradiation (spectrum b in Figure 4A). The fluorescence decay was bi-exponential with lifetimes of τf = 0.50 ns (63.70%) and τs = 2.10 ns (36.30%), respectively. The fluorescence decay after the photolysis was complete exhibited again a bi-exponential behavior with slight changes in the lifetimes and the related amplitudes, being, τf = 0.70 ns (52.40%) and τs = 2.70 ns (47.60%), respectively. Analogously to what was already observed for NBF-NO, the bi-exponential behavior could be due to the different environments experienced by the fluorophore within the host compartment.
Preliminary antibacterial activity of the supramolecular complexes γ-CDng/NBF-NO and γ-CDng/RHD-NO and, for comparison of the only host, γ-CDng were evaluated on Gram-positive methicillin-resistant Staphylococcus aureus (MRSA. This bacterium is responsible for higher rate of morbidity due to its high antibiotic-resistance pattern towards traditional antibiotics. The bacterial cultures were either kept in the dark or irradiated at different times with visible light (see experimental).
The results reported in Table 1 show that the empty γ-CDng does not have any significant effect on the bacterial load either in the dark or under illumination. No significant reduction was also observed for γ-CDng/NBF-NO under the same experimental conditions. In contrast, a significant inhibitor effect was observed in the case of γ-CDng/RHD-NO under light irradiation in a fashion dependent on the irradiation time, as confirmed by the reduction of ca. 3 and more than 5 log units after 4 and 8 min of irradiation, respectively.
By taking into account the high NO photogeneration quantum yield of γ-CDng/NBF-NO compared to γ-CDng/RHD-NO (see above), the results obtained seem quite surprising. To gain insights into this apparent incongruence and taking advantage of the fluorescence properties of both NOPDs, we carried out fluorescence microscopy investigations. Figure 5 shows representative images obtained after incubating the bacteria with the NOPDs for 20 min, followed by washing (see experimental). No detectable green fluorescence was observed in the case of the γ-CDng/NBF-NO (poorly fluorescent) and its highly fluorescent photoproduct γ-CDng/NBF (Figure 5A,B). In contrast, clearly visible red fluorescence was observed for γ-CDng/RHD-NO. These findings suggest that the difference in the antibacterial action of the two NOPDs is probably due to their different interaction with bacteria.

3. Materials and Methods

3.1. Materials

All chemicals were purchased from Sigma-Aldrich and used without further purification. γ-CDng, γ-CDng/NBF-NO and γ-CDng/RHD-NO were prepared according to our previously reported procedures [25,26,27]. All solvents used for the spectrophotometric studies were of spectrophotometric grade. MilliQ water was used for polymer solubilization and all chemical and photochemical experiments.

3.2. Instrumentation

UV-Vis absorption spectra were recorded with a JascoV-560 spectrophotometer. Vis fluorescence emission spectra were recorded with a Spex Fluorolog-2 (mod. F-111) spectrofluorimeter. All spectra have been collected under air-equilibrated conditions using quartz cells with a path length of 1 cm. Fluorescence decays were acquired with the same fluorimeter as above equipped with a TCSPC Triple Illuminator. The samples were excited with a pulsed diode excitation source (Nanoled) at λexc = 455 nm, and the decays were collected at λem = 530 and 587 nm for γ-CDng/NBF-NO and γ-CDng/RHD-NO, respectively. The system allowed measurement of fluorescence lifetimes with a time resolution of 200 ps. The multiexponential fit of the fluorescence decay was obtained using the following equation:
I(t) = Σαiexp(−t/τi)
where I is the fluorescence intensity, α is the relative amplitude and τ is the lifetime.
All photolysis experiments were performed by irradiating the samples in thermostated quartz cells (with path length of 1 cm and capacity of 3 mL) under gentle stirring, using a continuum laser at λexc = 405 nm or λexc = 532 nm and having a beam diameter of ca. 1.5 mm.
NO release in solution was monitored by a direct method through amperometric detection with an ISO-NO meter (World Precision Instruments) having short response time (<5 s) and sensitivity in the range 1 nM–20 µM and equipped with a data acquisition system. The analogue signal was digitalized with a four-channel recording system and then transferred to a PC. The NO sensor was firstly accurately calibrated by known amounts of NO produced by mixing standard solutions of NaNO2 with 0.1 M H2SO4 and 0.1 M KI according to the following reaction:
4H+ + 2I + 2NO2 → 2H2O + 2NO + I2
Irradiation was performed in a thermostated quartz cell (1 cm path length, 3 mL capacity) using the continuum laser at λexc = 405 nm or λexc = 532 nm. To avoid NO signal artefacts due to photoelectric interference on the ISO-NO electrode, all NO measurements were carried out under gentle stirring, positioning the electrode outside the light path.
The size distribution was determined on a Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, UK).

3.3. NO Photorelease Quantum Yields

NO photorelease quantum yields, ΦNO, were determined within the 20% transformation of γ-CDng/NBF-NO and γ-CDng/RHD-NO by using the following equation:
ΦNO = [T] × V/t × (1 − 10−A) × I
where [T] is the concentration of phototransformed γ-CDng/NBF-NO and γ-CDng/RHD-NO, V is the volume of the irradiated sample, t is the irradiation time, A is the absorbance of the sample at the excitation wavelength and I the intensity of the excitation light source. The concentration of the phototransformed γ-CDng/NBF-NO and γ-CDng/RHD-NO were determined spectrophotometrically by taking into account the absorption changes at λ = 382 nm (∆ε382 = 12,000 M−1 cm−1) and λ = 400 nm (∆ε400 = 7500 M−1 cm−1). I was calculated via potassium ferrioxalate actinometry.

3.4. Preparation of the Supramolecular Complexes

Stock solutions of NBF-NO and RHD-NO were prepared in MeOH. Afterwards the solvent was evaporated under reduced pressure at 25 °C. The resulting film was rehydrated with an aqueous solution of γ-CDng (1 mg mL−1) by stirring for 4 h at room temperature.
Encapsulation efficiency (EE %) was calculated using the following:
EE % = (WIN/Wi) × 100
where WIN is the amount of drug in the nanoassembly and Wi is the total amount of drug added initially during preparation.

3.5. Biological Assays

3.5.1. Antibacterial Activity

The activity of the different samples was investigated against Staphylococcus aureus (MRSA) ATCC 43300. The overnight broth cultures grown in Mueller Hinton Broth (MHB) were centrifuged at 3500 rpm for 15 min, washed with phosphate-buffered saline (PBS) at pH 7.2 and resuspended in order to obtain a final density of approximatively 1–2 × 107 colony forming unit (CFU) mL−1 by optical density measurements at 570 nm. Twenty µL of the bacterial suspension were placed into a 96-well microplate containing 180 µL of each Hydrogel sample. The microplate was irradiated for 4′ and 8′ by using a 150 W Xe lamp equipped with a cut-off filter at λ > 400 nm or kept in the dark. At the end of the irradiation each sample whole and serially diluted in PBS was drop-plated in duplicate on Mueller Hinton Agar (MHA) plate and incubated at 37 °C for 24–48 h. Later, colonies were counted at the most appropriate dilution and expressed as CFU mL−1. PBS was included as growth control.

3.5.2. Fluorescence Microscopy

The overnight broth culture of methicillin-resistant S. aureus (MRSA) ATCC 43300 was washed twice and suspended in PBS. The cell suspension (108 CFU mL−1) was treated with different samples and incubated under dark conditions for 20 min. Controls without samples were included. After incubation, the bacterial cells were harvested by centrifugation at 12,000 rpm for 10 min and washed twice with PBS. The cell suspensions were spotted onto glass slides and then the coverslips were mounted. The images were analyzed using a LEICA fluorescence microscope (Leitz, Wetzlar, Germany).

4. Conclusions

We have shown that two water-insoluble NOPDs can be supramolecularly encapsulated within a water dispersible γ-CDng with excellent preservation of their photochemical properties. Excitation of the γ-CDng/NBF-NO and γ-CDng/RHD-NO nanoassemblies with blue and green light, respectively, triggers the NO release with quantum efficiencies very similar to those observed for the free gusts in the organic solvent. Moreover, the photoactivatable and persistent fluorescence properties of NBF-NO and RHD-NO, respectively, are well maintained in the supramolecular complexes, with only minor changes observed in the fluorescence lifetimes. We outline that such results are not trivial. In fact, in many cases, the photobehavior of guest molecules confined in a restricted host nanoenvironment in the presence of steric constrains and specific interactions may lead to significant modification of the main photodeactivation pathways observed for the free guests in the nature, efficiency or both. In the present case, the preservation of nature and efficiency of the photochemical processes is mainly the result of (i) the lack of self-aggregation/quenching processes of the NOPDs, although confined in a small-sized host, in which they are preferentially encapsulated as monomeric forms; (ii) the key role that the CD units of the nanogel play as good hydrogen donors towards the nitrogen-centered radical intermediates generated after the light-triggered homolytic rupture of the N-NO bond.
Preliminary antibacterial tests carried out on MRSA have demonstrated that γ-CDng/RHD-NO is very active in inhibiting the bacteria load, although this NOPD produces NO with efficiency lower than that of γ-CDng/NBF-NO, which, in contrast, shows only negligible antibacterial activity. Fluorescence microscopy experiments suggest that this apparent discrepancy could be due to the different affinity of the NOPDs for the bacterial cells.

Author Contributions

Conceptualization, S.S.; methodology and investigation, T.J.M., C.P., Y.S., T.H. (Takeshi Hashimoto), A.N. and G.G.; validation, T.J.M. and C.P.; data curation, T.J.M. and C.P.; writing—original draft preparation, S.S.; editing, S.S. and T.H. (Takashi Hayashita); supervision, S.S. and T.H. (Takashi Hayashita). All authors have read and agreed to the published version of the manuscript.

Funding

HORIZON-MSCA-2021-PF-01, 101057562—SUPREME: JSPS Grant-in-Aid for Scientific Research Grant Number 20H02772; JSPS Research Fellowship for Young Scientists PD Grant Numbers 21J00709 and 22KJ2748.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank HORIZON-MSCA-2021-PF-01, 101057562—SUPREME for their financial support to MC fellow TJM and funding the research. We also thank the financial supports of a JSPS Grant-in-Aid for Scientific Research Grant Number 20H02772 and a JSPS Research Fellowship for Young Scientists PD Grant Number 21J00709 for Y. Suzuki. We are grateful to M.T. Sciortino (University of Messina) for the assistance in fluorescence microscopy.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not available.

References

  1. Ignarro, L.J. Nitric Oxide: Biology and Pathobiology, 3rd ed.; Academic Press: Cambridge, MA, USA, 2017; p. 411. [Google Scholar]
  2. Wink, D.A.; Mitchell, J.B. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 1998, 25, 434–456. [Google Scholar] [CrossRef] [PubMed]
  3. Malone-Povolny, M.J.; Maloney, S.E.; Schoenfisch, M.H. Nitric Oxide Therapy for Diabetic Wound Healing. Adv. Healthc. Mater. 2019, 8, 1801210. [Google Scholar] [CrossRef] [PubMed]
  4. Yang, L.; Feura, E.S.; Ahonen, M.J.R.; Schoenfisch, M.H. Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications. Adv. Healthc. Mater. 2018, 7, 1800155. [Google Scholar] [CrossRef] [PubMed]
  5. Navale, G.R.; Singh, S.; Ghosh, K. NO donors as the wonder molecules with therapeutic potential: Recent trends and future perspectives. Coord. Chem. Rev. 2023, 481, 215052. [Google Scholar] [CrossRef]
  6. Wang, P.G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; Cai, T.; Janczuk, A.J. Nitric oxide donors: Chemical activities and biological applications. Chem. Rev. 2002, 102, 1091–1134. [Google Scholar] [CrossRef]
  7. Riccio, D.A.; Schoenfisch, M.H. Nitric oxide release: Part I. Macromolecular scaffolds. Chem. Soc. Rev. 2012, 41, 3731–3741. [Google Scholar] [CrossRef]
  8. Carpenter, A.W.; Schoenfisch, M.H. Nitric oxide release: Part II. Therapeutic applications. Chem. Soc. Rev. 2012, 41, 3742–3752. [Google Scholar] [CrossRef] [Green Version]
  9. Seabra, A.B.; Durán, N. Nitric oxide-releasing vehicles for biomedical applications. J. Mat. Chem. 2010, 20, 1624–1637. [Google Scholar] [CrossRef] [Green Version]
  10. Sortino, S. Light-controlled nitric oxide delivering molecular assemblies. Chem. Soc. Rev. 2010, 39, 2903–2913. [Google Scholar] [CrossRef]
  11. Fraix, A.; Parisi, C.; Seggio, M.; Sortino, S. Nitric Oxide Photoreleasers with Fluorescent Reporting. Chem. Eur. J. 2021, 27, 12714–12725. [Google Scholar] [CrossRef]
  12. Ford, P.C. Photochemical delivery of nitric oxide. Nitric Oxide 2013, 34, 56–64. [Google Scholar] [CrossRef] [Green Version]
  13. Ostrowski, A.D.; Ford, P.C. Metal complexes as photochemical nitric oxide precursors: Potential applications in the treatment of tumors. Dalton Trans. 2009, 48, 10660–10669. [Google Scholar] [CrossRef]
  14. Fry, N.L.; Mascharak, P.K. Photoactive Ruthenium Nitrosyls as NO Donors: How to Sensitize Them toward Visible Light. Acc. Chem. Res. 2011, 44, 289–298. [Google Scholar] [CrossRef]
  15. Ieda, N.; Oka, Y.; Yoshihara, T.; Tobita, S.; Sasamori, T.; Kawaguchi, M.; Nakagawa, H. Structure-efficiency relationship of photoinduced electron transfer-triggered nitric oxide releasers. Sci. Rep. 2019, 9, 1430. [Google Scholar] [CrossRef] [Green Version]
  16. de Lima, R.G.; Rios, R.R.; Machado, A.E.D.H.; da Silva, R.S. Ruthenium phthalocyanines in nitric oxide modulation and singlet oxygen release: Selectivity and cytotoxic effect on cancer cell lines. Adv. Inorg. Chem. 2022, 80, 355–379. [Google Scholar]
  17. Fraix, A.; Marino, N.; Sortino, S. Phototherapeutic Release of Nitric Oxide with Engineered Nanoconstructs. Top. Curr. Chem. 2016, 370, 225–257. [Google Scholar]
  18. Suhail, M.; Rosenholm, J.M.; Minhas, M.U.; Badshah, S.F.; Naeem, A.; Khan, K.U.; Fahad, M. Nanogels as drug-delivery systems: A comprehensive overview. Ther. Deliv. 2019, 10, 697–717. [Google Scholar] [CrossRef]
  19. Vinogradov, S.V.; Bronich, T.K.; Kabanov, A.V. Nanosized cationic hydrogels for drug delivery: Preparation, properties and interactions with cells. Adv. Drug Deliv. Rev. 2002, 54, 135–147. [Google Scholar] [CrossRef] [Green Version]
  20. Szejtli, J. Cyclodextrin Technology, 1st ed.; Kluwer: Dordrecht, The Netherlands, 1988; p. 450. [Google Scholar]
  21. Liu, Y.Y.; Yu, Y.; Tian, W.; Sun, L.; Fan, X.-D. Preparation and Properties of Cyclodextrin/PNIPAm Microgels. Macromol. Biosci. 2009, 9, 525–534. [Google Scholar] [CrossRef]
  22. Swaminathan, S.; Pastero, L.; Serpe, L.; Trotta, F.; Vavia, P.; Aquilano, D.; Trotta, M.; Zara, G.; Cavalli, R. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm. 2010, 74, 193–201. [Google Scholar] [CrossRef]
  23. Lu, D.; Yang, L.; Zhou, T.; Lei, Z. Synthesis, characterization and properties of biodegradable polylactic acid-β-cyclodextrin cross-linked copolymer microgels. Eur. Polym. J. 2008, 44, 2140–2145. [Google Scholar] [CrossRef]
  24. Moya-Ortega, M.D.; Alvarez-Lorenzo, C.; Sigurdsson, H.H.; Concheiro, A.; Loftsson, T. Cross-linked hydroxypropyl-β-cyclodextrin and γ-cyclodextrin nanogels for drug delivery: Physicochemical and loading/release properties. Carbohydr. Polym. 2012, 87, 2344–2351. [Google Scholar] [CrossRef]
  25. Takeuchi, S.; Cesari, A.; Soma, S.; Suzuki, Y.; Casulli, M.A.; Sato, K.; Mancin, F.; Hashimoto, T.; Hayashita, T. Preparation of ultrasmall cyclodextrin nanogels by an inverse emulsion method using a cationic surfactant. Chem. Commun. 2023, 59, 4071–4074. [Google Scholar] [CrossRef] [PubMed]
  26. Parisi, C.; Seggio, M.; Fraix, A.; Sortino, S. A High-Performing Metal-Free Photoactivatable Nitric Oxide Donor with a Green Fluorescent Reporter. ChemPhotoChem 2020, 4, 742–748. [Google Scholar] [CrossRef]
  27. Parisi, C.; Failla, M.; Fraix, A.; Rolando, B.; Gianquinto, E.; Spyrakis, F.; Gazzano, E.; Riganti, C.; Lazzarato, L.; Fruttero, R.; et al. Fluorescent nitric oxide photodonors based on BODIPY and rhodamine antennae. Chem. Eur. J. 2019, 25, 11080–11084. [Google Scholar] [CrossRef]
Scheme 1. Sketch of the γ-CDng and molecular structures and working principles of the water-insoluble NOPDs.
Scheme 1. Sketch of the γ-CDng and molecular structures and working principles of the water-insoluble NOPDs.
Molecules 28 05665 sch001
Figure 1. (A) Absorption spectrum of the supramolecular complex γ-CDng/NBF-NO (a) and spectral changes observed upon irradiation of this sample at λexc = 405 nm (ca. 30 mW cm−2). The arrows indicate the course of the spectral profile with the illumination time. The insets show the actual image of sample a taken under ambient light (left) and the absorbance changes at λ = 382 (■) and 480 nm (○), respectively (right). (B) NO release profile (λexc = 405 nm) observed for γ-CDng/NBF-NO. [γ-CDng] = 1 mg mL−1; [NBF-NO] = 20 µM; T = 25 °C.
Figure 1. (A) Absorption spectrum of the supramolecular complex γ-CDng/NBF-NO (a) and spectral changes observed upon irradiation of this sample at λexc = 405 nm (ca. 30 mW cm−2). The arrows indicate the course of the spectral profile with the illumination time. The insets show the actual image of sample a taken under ambient light (left) and the absorbance changes at λ = 382 (■) and 480 nm (○), respectively (right). (B) NO release profile (λexc = 405 nm) observed for γ-CDng/NBF-NO. [γ-CDng] = 1 mg mL−1; [NBF-NO] = 20 µM; T = 25 °C.
Molecules 28 05665 g001
Figure 2. (A) Evolution of the fluorescence emission spectra recorded at λexc = 427 nm (isosbestic point) of the supramolecular complex γ-CDng/NBF-NO upon irradiation at λexc = 405 nm (ca. 30 mW cm−2). The arrow indicates the course of the spectral profile from 0 to 48 s. The inset shows variation of the fluorescence intensity monitored at λem = 550 nm; I and I0 represent the fluorescence intensities after each step of irradiation and the initial value before irradiation, respectively. (B) Actual images of the γ-CDng/NBF-NO acquired under illumination with a blue LED at different irradiation times. (C) Fluorescence decay profile acquired at the end of the photolysis and monitored at λem = 530 nm. [γ-CDng] = 1 mg mL−1; [NBF-NO] = 20 µM; T = 25 °C.
Figure 2. (A) Evolution of the fluorescence emission spectra recorded at λexc = 427 nm (isosbestic point) of the supramolecular complex γ-CDng/NBF-NO upon irradiation at λexc = 405 nm (ca. 30 mW cm−2). The arrow indicates the course of the spectral profile from 0 to 48 s. The inset shows variation of the fluorescence intensity monitored at λem = 550 nm; I and I0 represent the fluorescence intensities after each step of irradiation and the initial value before irradiation, respectively. (B) Actual images of the γ-CDng/NBF-NO acquired under illumination with a blue LED at different irradiation times. (C) Fluorescence decay profile acquired at the end of the photolysis and monitored at λem = 530 nm. [γ-CDng] = 1 mg mL−1; [NBF-NO] = 20 µM; T = 25 °C.
Molecules 28 05665 g002
Figure 3. (A) Absorption spectrum of the supramolecular complex γ-CDng/RHD-NO (a) and spectral changes observed upon exposure of this sample at λexc = 532 nm (ca. 200 mW cm−2). The arrows indicate the course of the spectral profile with the illumination time. The insets show the actual image of sample a taken under ambient light (right) and the difference absorbance changes at λ = 400 nm (left). (B) NO release profile (λexc = 532 nm) observed for γ-CDng/NBF-NO. [γ-CDng] = 1 mg mL−1; [RHD-NO] = 6 µM; T = 25 °C.
Figure 3. (A) Absorption spectrum of the supramolecular complex γ-CDng/RHD-NO (a) and spectral changes observed upon exposure of this sample at λexc = 532 nm (ca. 200 mW cm−2). The arrows indicate the course of the spectral profile with the illumination time. The insets show the actual image of sample a taken under ambient light (right) and the difference absorbance changes at λ = 400 nm (left). (B) NO release profile (λexc = 532 nm) observed for γ-CDng/NBF-NO. [γ-CDng] = 1 mg mL−1; [RHD-NO] = 6 µM; T = 25 °C.
Molecules 28 05665 g003
Figure 4. (A) Fluorescence emission spectra recorded at λexc = 510 nm of the supramolecular complex γ-CDng/RHD-NO before (a) and after (b) photolysis with green light. The inset shows the actual image of the γ-CDng/RHD-NO acquired under illumination with a blue LED (B) Fluorescence decay profile of γ-CDng/RHD-NO acquired before photolysis and monitored at λem = 587 nm. [γ-CDng] = 1 mg mL−1; [RHD-NO] = 6 µM; T = 25 °C.
Figure 4. (A) Fluorescence emission spectra recorded at λexc = 510 nm of the supramolecular complex γ-CDng/RHD-NO before (a) and after (b) photolysis with green light. The inset shows the actual image of the γ-CDng/RHD-NO acquired under illumination with a blue LED (B) Fluorescence decay profile of γ-CDng/RHD-NO acquired before photolysis and monitored at λem = 587 nm. [γ-CDng] = 1 mg mL−1; [RHD-NO] = 6 µM; T = 25 °C.
Molecules 28 05665 g004
Figure 5. Fluorescence microscopy images obtained after incubation and following washing of (A) γ-CDng/NBF-NO, (B) γ-CDng/NBF, and (C) γ-CDng/RHD-NO with S. aureus (MRSA) ATCC 43300.
Figure 5. Fluorescence microscopy images obtained after incubation and following washing of (A) γ-CDng/NBF-NO, (B) γ-CDng/NBF, and (C) γ-CDng/RHD-NO with S. aureus (MRSA) ATCC 43300.
Molecules 28 05665 g005
Table 1. Activity of different samples against methicillin-resistant S. aureus (MRSA) ATCC 43300 in the dark and under visible light irradiation. Results are reported as the mean of three separate measurements on three different batches ± SD.
Table 1. Activity of different samples against methicillin-resistant S. aureus (MRSA) ATCC 43300 in the dark and under visible light irradiation. Results are reported as the mean of three separate measurements on three different batches ± SD.
SampleTime (min)Dark
Log CFU mL−1
Light
Log CFU mL−1
Inoculum06.36 ± 0.03
PBS46.23 ± 0.036.19 ± 0.06
γ-CDng46.18 ± 0.106.15 ± 0.04
γ-CDng/NBF-NO46.07 ± 0.086.07 ± 0.04
γ-CDng/RHD-NO46.15 ± 0.113.36 ± 0.08
PBS86.21 ± 0.086.14 ± 0.09
γ-CDng86.17 ± 0.056.13 ± 0.05
γ-CDng/NBF-NO86.07 ± 0.096.06 ± 0.09
γ-CDng/RHD-NO85.84 ± 0.041.46 ± 0.15
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Martins, T.J.; Parisi, C.; Suzuki, Y.; Hashimoto, T.; Nostro, A.; Ginestra, G.; Hayashita, T.; Sortino, S. Supramolecular Assemblies of Fluorescent Nitric Oxide Photoreleasers with Ultrasmall Cyclodextrin Nanogels. Molecules 2023, 28, 5665. https://doi.org/10.3390/molecules28155665

AMA Style

Martins TJ, Parisi C, Suzuki Y, Hashimoto T, Nostro A, Ginestra G, Hayashita T, Sortino S. Supramolecular Assemblies of Fluorescent Nitric Oxide Photoreleasers with Ultrasmall Cyclodextrin Nanogels. Molecules. 2023; 28(15):5665. https://doi.org/10.3390/molecules28155665

Chicago/Turabian Style

Martins, Tassia J., Cristina Parisi, Yota Suzuki, Takeshi Hashimoto, Antonia Nostro, Giovanna Ginestra, Takashi Hayashita, and Salvatore Sortino. 2023. "Supramolecular Assemblies of Fluorescent Nitric Oxide Photoreleasers with Ultrasmall Cyclodextrin Nanogels" Molecules 28, no. 15: 5665. https://doi.org/10.3390/molecules28155665

Article Metrics

Back to TopTop